Read More

Cannabis Products To Try This Summer, Here’s What Tilray Has In Store

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Wednesday the Good Supply launch of its 'Summer Shareability' campaign. The Canadian cannabis giant said "The brand is putting their most shareable and convenient formats front and center, along with exciting flavors that are perfect for any warm weather gathering," to celebrate the summer months.

TLRY

Read More

Germany Sets THC Limits For Drivers, Opposition Groups Say It’s Too High

Lawmakers in Germany have set a maximum allowed limit of THC – tetrahydrocannabinol, a psychoactive substance found in the cannabis plant- for drivers to have in the blood. The Bundestag, the country's lower house of parliament, introduced this week a limit of 3.5 nanograms per milliliter. As DW highlighted that's an equivalent to 20 milligrams of alcohol per 100 milliliters of blood. The decision builds on a recommendation by an expert panel commissioned by the Transport Ministry.

ACB

Read More

Tilray Ramps Up Its Cannabis Portfolio In Canada, Wins International Spirits Competition

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Thursday the launch of 'Purple Churro,' by Redecan cannabis.The new sativa offers "a sweet, indulgent experience with a potent twist and boasting THC levels," the Canadian cannabis giant said in a press release.Purple Churro is a cross of Cinnamon Horchata and Apples & Bananas, featuring a blend of sweet vanilla and cinnamon-tasting notes.In the meantime, the company's liquor business is celebrating two wins at the 15th annual New York International Spirits Competition. Tilray's subsidiary Breckenridge Distillery was a winner at Colorado American Blended Whiskey Distillery of the Year and Double Gold for Breckenridge Port Cask Finish.

TLRY

Read More

Cannabis Giant Tilray Reports 30% YoY Increase In Q3 Net Revenue, Updates FY 2024 Guidance

Tilray Brands reported on Tuesday financial results for its third quarter ended Feb. 29, 2024, revealing $188.3 million in net revenue, representing a 30% year-over-year increase. The Canadian medical cannabis company said beverage-alcohol net revenue increased 165% over the same period to $54.7 million. Global cannabis net revenue was up 33% year-over-year reaching $63.4 million, with international cannabis growth of 44% over the prior year quarter. "We made several notable achievements during the third quarter, including growing revenue across our core business segments, increasing our adjusted gross profit, reducing our convertible debt balance, progressing the integration of our recently acquired craft beverage brands, realizing operating synergies in integrating our HEXO acquisition, completing our Canadian and international cannabis cost reduction plans, and strengthening our balance sheet," Irwin D. Simon, the company's chairman and CEO, said.

TLRY

Read More

Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows

Older patients comprise a growing subset of medical cannabis patients, according to a new study. Titled Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada, the new scientific publication presented the consumption trends observed in patients and the self-reported impacts of medical cannabis in alleviating the patients' primary symptoms. Tilray Medical, a division of Tilray Brands, Inc. is behind the study which is derived from the Canadian Cannabis Patient Survey (CCPS) 2021, which included 2,697 patients. The researchers focused primarily on older patients with a mean age of 54.3. Patients with chronic pain (27.8%), arthritis (14.9%) and anxiety (9%) were the most numerous among those seeking cannabis to treat their primary illnesses. Pain was the most common primary symptom for which patients use medical cannabis, followed by anxiety and insomnia/sleep disorder.

TLRY

Read More

Tilray’s Diversified Growth Strategy Is Paying Off, Here’s What’s Behind 34% YoY Revenue Increase In Q2

Canadian cannabis company Tilray reported a 34% increase in revenue in its second quarter of fiscal 2024. The company reported revenue of $194 million, up from $145 million in the same period last year. Tilray's cannabis net revenue increased 35% to $67 million, while beverage alcohol net revenue increased 117% to $47 million. Distribution net revenue also rose to $67 million, compared to $60 million in the same quarter last year. The company's gross profit increased 11% to $47 million, with adjusted gross profit up 18% to $52 million. Net loss in the second quarter amounted to $46 million, compared to a net loss of $62 million in the same period last year. Adjusted EBITDA stood at $10.1 million, down from $11 million in Q2 2023.

TLRY

Read More

Tilray Expands Weed Drink Selection, Here’s What RIFF Brand Has In Store For Cannaseurs

Canadian cannabis company Tilray has launched two new ready-to-drink THC and CBG-infused beverages as part of its RIFF brand. The RIFF BOOST drinks are available in Tropical Burst and Vanilla Frost flavours, and each contains 10mg of THC, 10mg of CBG and 30mg of naturally occurring caffeine from guarana extract. The beverages are available in 355ml cans. Tilray's RIFF brand debuted its first cannabis-infused beverages in July, with the introduction of sparkling THC drinks in Blue Raspberry Ice and Wild Raspberry Lemonade flavours. The new RIFF BOOST drinks are available in select regions and retailers in Canada, including Alberta, Manitoba and Ontario. Tilray expanded its cannabis beverage portfolio in November with products from its XMG and Mollo brands.

TLRY

Read More

Tilray’s Chowie Wowie Launches New Weed Chocolates Just On Time For The Holidays, Here’s Where To Find Them

Tilray Brands, the Canadian cannabis company, has announced the expansion of its Chowie Wowie brand with the release of two new cannabis-infused chocolates. The new flavors, Soft Caramel and Crunchy Praline, join the brand's existing line-up of chocolates, which includes Balanced Milk Chocolate and THC Milk Chocolate. Chowie Wowie chocolates are made with premium Belgian chocolate and are currently available in various provinces across Canada. Each chocolate contains 10mg of THC and either 10mg of CBD or 10mg of THC and CBD.

TLRY